(2S)-2-[(S)-({2-[(1-methylethyl)oxy]phenyl}thio)(phenyl)methyl]morpholine | 668470-67-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (2S)-2-[(S)-({2-[(1-methylethyl)oxy]phenyl}thio)(phenyl)methyl]morpholine
• 英文别名: (2S)-2-[Phenyl({2-[(propan-2-yl)oxy]phenyl}sulfanyl)methyl]morpholine；(2S)-2-[(S)-phenyl-(2-propan-2-yloxyphenyl)sulfanylmethyl]morpholine
• CAS: 668470-67-5
• 化学式: C₂₀H₂₅NO₂S
• 分子量: 343.49
• InChiKey: AHSXCJDSPAMLCP-ICSRJNTNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  55.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  生成 (2S)-2-[(S)-({2-[(1-methylethyl)oxy]phenyl}thio)(phenyl)methyl]morpholine
  参考文献：
  名称：

  [EN] 2- (PHENOXYMETHYL)- AND 2- (PHENYLTHIOMETHYL)-MORPHOLINE DERIVATIVES FOR USE AS SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITORS
  [FR] DERIVES DE MORPHOLINE

  摘要：

  公开号：

  WO2004017977A3

文献信息

• Morpholine derivatives
  申请人：Walter Wilhelm Magnus

  公开号：US20060035894A1

  公开（公告）日：2006-02-16

  Compounds of formula (I): wherein A is S or O; R is H; Ar is an optionally substituted phenyl group; X is an optionally substituted phenyl group, a C 1 -C 4 alkyl, a C 3 -C 6 cycloalkyl group or a CH 2 (C 3 -C 6 cycloalkyl) group; R′ is H or C 1 -C 4 alkyl; and each R 1 is independently H or C 1 -C 4 alkyl; and pharmaceutically acceptable salts thereof are selective inhibitors of norepinephrine reuptake.

  分子式为（I）的化合物：其中A为S或O；R为H；Ar为可选取代的苯基；X为可选取代的苯基、C1-C4烷基、C3-C6环烷基或CH2（C3-C6环烷基）基；R'为H或C1-C4烷基；每个R1独立地为H或C1-C4烷基；以及其药物可接受的盐是去甲肾上腺素再摄取的选择性抑制剂。
• 2-(PHENYLTHIOMETHYL)- MORPHOLINE DERIVATIVES FOR USE AS SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITORS
  申请人：ELI LILLY AND COMPANY

  公开号：EP1534291B1

  公开（公告）日：2008-11-12
• TREATMENT OF LEARNING DISABILITIES AND MOTOR SKILLS DISORDER WITH NOREPINEPHRINE REUPTAKE INHIBITORS
  申请人：ELI LILLY AND COMPANY

  公开号：EP1660064A2

  公开（公告）日：2006-05-31
• TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH NOREPINEPHRINE REUPTAKE INHIBITORS
  申请人：ELI LILLY AND COMPANY

  公开号：EP1660065A2

  公开（公告）日：2006-05-31
• Treatment of pervasive developemental disorders with norepinephrine reuptake inhibitors
  申请人：Allen John Albert

  公开号：US20060241188A1

  公开（公告）日：2006-10-26

  Provided are methods and medicaments for treating a Pervasive Developmental Disorder, comprising administering to a patient in need of such treatment an effective amount of a selective norepinephrine reuptake inhibitor.